ArticleBMC health services research2003
Cost of managing complications resulting from type 2 diabetes mellitus in Canada.
Article in BMC health services research, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
37 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Determining direct, indirect healthcare and social costs for diabetic retinopathy management: a systematic review.BMC ophthalmology · 2024Pooled it
- Description of a New Predictive Modeling Approach That Correlates the Risk and Associated Cost of Well-Defined Diabetes-Related Complications With Changes in Glycated Hemoglobin (HbA1c).Journal of diabetes science and technology · 2017Pooled it
- Development and validation of a type 2 diabetes model to estimate the cost-effectiveness of diabetes interventions across the care continuum.International journal of technology assessment in health care · 2025Article
- Screening for Diabetes Complications during the COVID-19 Outbreak in South Korea.International journal of environmental research and public health · 2022Article
- Priorities among effective clinical preventive services in British Columbia, Canada.BMC health services research · 2022Article
- Estimating treatment costs for uncomplicated diabetes at a hospital serving refugees in Kenya.PloS one · 2022Article
- Association of diabetes type and chronic diabetes complications with early exit from the labour force: register-based study of people with diabetes in Finland.Diabetologia · 2021Article
- Identifying Barriers and Enablers to Attending Diabetic Retinopathy Screening in Immigrants to Canada From Ethnocultural Minority Groups: Protocol for a Qualitative Descriptive Study.JMIR research protocols · 2020Article
- Cost Effectiveness of Once-Weekly Semaglutide Versus Once-Weekly Dulaglutide in the Treatment of Type 2 Diabetes in Canada.PharmacoEconomics - open · 2019 · on this mapArticle
- Healthcare costs and utilization of diabetes-related complications in Taiwan: A claims database analysis.Medicine · 2018Article
- Cost-effectiveness of magnetic resonance carotid plaque imaging for primary stroke prevention in Canada.The British journal of radiology · 2018Article
- Cognitive Behavioural Therapy for Psychosis: A Health Technology Assessment.Ontario health technology assessment series · 2018Review
- Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment.Ontario health technology assessment series · 2018Article
- Relationship Between Adiponectin and apoB in Individuals With Diabetes in the Atlantic PATH Cohort.Journal of the Endocrine Society · 2017Article
- Article
- Economic analysis of insulin initiation by pharmacists in a Canadian setting: The RxING study.Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC · 2016Article
- Economic Value of Improved Accuracy for Self-Monitoring of Blood Glucose Devices for Type 1 Diabetes in Canada.Journal of diabetes science and technology · 2015Article
- Economic evaluation of hormonal therapies for postmenopausal women with estrogen receptor-positive early breast cancer in Canada.Current oncology (Toronto, Ont.) · 2015Article
- Economic burden of illness associated with diabetic foot ulcers in Canada.BMC health services research · 2015Article
- Effectiveness of the smart care service for diabetes management.Healthcare informatics research · 2014Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDecision makers need to have Canadian-specific cost information in order to develop an accurate picture of diabetes management. The objective of this study is to estimate direct medical costs of managing complications of diabetes. Complication costs were estimated by applying unit costs to typical resource use profiles. For each complication, the event costs refer to those associated with the acute episode and subsequent care in the first year. State costs are the annual costs of continued management. Data were obtained from many Canadian sources, including the Ontario Case Cost Project, physician and laboratory fee schedules, formularies, reports, and literature. All costs are expressed in 2000 Canadian dollars.
resultsMajor events (e.g., acute myocardial infarction: 18,635 dollars event cost; 1,193 dollars state cost), generate a greater financial burden than early stage complications (e.g., microalbuminuria: 62 dollars event cost; 10 dollars state cost). Yet, complications that are initially relatively low in cost (e.g., microalbuminuria) can progress to more costly advanced stages (e.g., end-stage renal disease, 63,045 dollars state cost).
conclusionsMacrovascular and microvascular complication costs should be included in any economic analysis of diabetes. This paper provides Canadian-based cost information needed to inform critical decisions about spending limited health care dollars on emerging new therapies and public health initiatives.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.